Detalhe da pesquisa
1.
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Prostate
; 84(8): 772-779, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38504659
2.
Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer.
Prostate
; 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38751206
3.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38832989
4.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38634928
5.
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.
BMC Urol
; 24(1): 71, 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38532370
6.
Psoas abscess in pregnancy: a review of the literature and suggestion of minimally invasive treatment options.
Arch Gynecol Obstet
; 309(3): 987-992, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36840770
7.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37248424
8.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37676282
9.
Levels and dynamics of estimated glomerular filtration rate and recurrent vascular events and death in patients with minor stroke or transient ischemic attack.
Eur J Neurol
; 29(9): 2716-2724, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35652747
10.
Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
Clin Chem Lab Med
; 56(6): 919-926, 2018 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-29329103
11.
Low-threshold Brillouin laser at 2 µm based on suspended-core chalcogenide fiber.
Opt Lett
; 39(16): 4651-4, 2014 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25121840
12.
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.
Cancers (Basel)
; 16(3)2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38339235
13.
Delayed symptomatic renal arteriovenous fistula in a 24 years old male following renal biopsy.
Urol Case Rep
; 53: 102675, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38404683
14.
Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma.
Radiat Oncol
; 19(1): 16, 2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38291439
15.
Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cureus
; 16(1): e53038, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38410284
16.
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
Am J Transl Res
; 16(1): 304-313, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38322559
17.
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
Clin Genitourin Cancer
; 22(2): 305-314.e3, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38087702
18.
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Target Oncol
; 2024 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38704759
19.
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
J Clin Oncol
; : JCO2301983, 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38657187
20.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37481365